Spring Co-Op 2027, Commercial Analytics, Market Access

Spring Co-Op 2027, Commercial Analytics, Market Access

Kickstart Your Career at Vertex! Are you ready to make a real impact? At Vertex, our mission is to tackle serious diseases and to change lives, for the better, for the future. Our aim is to give you the skills, insights, and career guidance to be an important part of that future; to turn your potential into progression. As a Vertex intern or co-op, you’ll work on meaningful projects, collaborate with talented teams, and learn from industry leaders. We’re passionate about innovation, inclusion, and supporting your growth—inside and outside the lab.

Why Vertex?

• Real Projects: You’ll work on assignments that make a real impact, not just busy work.
• Mentorship & Networking: Connect with leaders and peers who want to see you succeed through professional networks, connections, and collaborations that will shape your longer-term career.
• Flexible & Supportive: We offer flexible work options with Flex @ Vertex and prioritize your wellbeing.
• Inclusive Culture: Collaboration and inclusion are embedded in everything we do.
• Career Launchpad: Build skills, explore career paths, and get guidance for your future career.

Your Impact

The Vertex Commercial Analytics, Market Access Co-Op is a 6-month experiential training program for students currently working towards an undergraduate or advanced degree in Engineering, Statistics, Analytics, STEM, or other related fields. If you are passionate, collaborative, and growth-minded, a co-op at Vertex will help you gain meaningful experience in our US Market Access functional areas and serve as a launchpad for your career.

The application deadline for this co-op is November 15th. Please note that Vertex reviews applications on a rolling basis and reserves the right to close this job posting prior to the listed deadline. Applicants can expect to receive an update about their application before or shortly after the application deadline.

What you will be doing: US Market Access analytics team functions as an analytics center of excellence for the market access strategy, trade & distribution, revenue forecasting and pricing teams. The analytics team supports use cases that help the different commercial business units ensure that patients with a script for Vertex products have access to the products through their health plans, pharmacies and sites-of-care.

The co-op commercial analytics will work with the US market access analytics team to work on forecasting and regression use cases that can help identify key drivers and barriers towards patient access for our pain and cystic fibrosis portfolio.

Key Responsibilities

• The co-op commercial analytics will work on several small initiatives each with a timeline of 3-4 weeks, the initial few weeks will be spent in training around US pharma and market access dynamics. The project profiles will be the following –
• Demand forecasting for pharmacies and hospitals
• Assessing the performance of contracts with payers and delivery networks
• Creating performance scorecards for payers
• Performing key driver analysis for identifying drivers of sales and access performance
• The co-op will report to the market access data analytics lead and work with them to learn about the data assets, business dynamics and create analytics scripts and reports and manage their tasks in collaboration with the data governance lead.

Qualifications

• A bachelor’s degree in quantitative discipline like engineering, statistics, analytics, computer science
• Currently pursuing a master’s degree in quantitative discipline or a STEM focused MBA
• Tools & technologies: SQL, Python (Pandas, sklearn)/R, Excel
• Quantitative

Skills

• Regression & hypothesis testing, key driver analysis, machine learning (classification), time series analysis, forecasting algorithms, SQL analytical window functions.
• Legal authorization to work in the United States, now and in the future. Please note that Vertex does not provide sponsorship for internships/co-ops or entry level roles within this part of the organization.
• You must be enrolled in an advanced degree program if graduating before May 2027
• You must be available to work full-time, 40 hours per week from January – July 2027

Program Details:

• Full-time, paid co-op $25.00 – 35.00 USD/hour

• Program Dates: January – July 2027

• Application Deadline: November 15th, 2026

• At Vertex, we believe that when you feel your best, you can perform at your best. That’s why our US benefits and global well-being resources are designed to support you.

• Free 24/7 onsite gym access and free access to group exercise classes

• Subsidized commuter benefits- transit and parking

• Provided meals—free breakfast daily!

• Career development opportunities and events, including C Suite engagement

• Social events—both intern-only and company-wide

• Location-specific perks and extras!

• Recognition of National Intern Day

• Our Ways of Working

• Flex Designation: Hybrid- Boston

• Flex Eligibility Status: Hybrid: work three days per week on-site with ad hoc flexibility.

• Note: The Flex status for this position is subject to Vertex’s Policy on Flex @ Vertex Program and may be changed at any time.

• This job posting is for a temporary role with a third-party agency partner that provides services to Vertex. The individual selected for this role will be offered the role as an employee of that third-party agency; compensation, medical benefits, fringe benefits and other terms and conditions of employment shall be presented by the third-party agency upon offer.

• At Vertex, we embrace continuous learning and encourage employees to stay informed on advances in AI, technology, automation, and industry trends. We seek talent who bring an external perspective, demonstrate curiosity and sound judgment, and thoughtfully adopt new capabilities that improve decision-making, drive innovation, increase efficiency, and help deliver better outcomes for patients.

• Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and conditions. The company has approved therapies for cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, acute pain and acromegaly, and it continues to advance clinical and research programs in these areas. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology.